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Evidence informed decision-making
Evidence-informed decision making is a global 
initiative that promotes the systematic use of health 
research evidence in policy and decision making. 
It means promotion of national partnerships 
between policy-makers, researchers and civil society 
representatives in order to facilitate both policy 
development and policy implementation through the 
use of the best scientific evidence available. 
• As a result, different sectors in the country 
jointly address specific priorities, develop and 
use specific skills to assess research evidence 
and to integrate them in policy briefs that 
provide for evidence-informed decisions by high-
level decision makers at both national and local 
levels. 
Challenges:
• What is the best evidence?
• How it could be assessed?
What is health technology assessment?
Health technology assessment (HTA) is a 
multidisciplinary activity that systematically examines 
the safety, clinical efficacy and effectiveness, cost-
effectiveness, organizational implications, social 
consequences, legal and ethical considerations of the 
application of a health technology – usually a drug, 
medical device or clinical/surgical procedure.
• Health technology can be defined broadly as any 
intervention that may be used to promote health, to 
prevent, diagnose or treat disease or for rehabilitation 
or long-term care. This includes the pharmaceuticals, 
devices, procedures and organizational systems used 
in health care
HTA acts as ‘a bridge’ between evidence and 
policy-making.
It seeks to provide health policy-makers with 
accessible, useable and evidence-based 
information to guide their decisions
about the appropriate use of technology and 
the efficient allocation of resources.
Different sectors in the country jointly address 
specific priorities, develop and use specific 
skills to assess research evidence and to 
integrate them in policy briefs 
HTA in Macedonia
• Activities related to:
-Countinous medical education since 2000
- Improvement of procedures in pharmaceutical sector -
regulatory and ethical aspect (procedures assessed and 
appropriately updated)
- Established Drug and Therapeutics Committees (DTC) in 
tertiary health care level
- Establishing   Drug expenditure control system Database –
ongoing
- Introduced pharmacoeconomic analysis for drugs  subject to 
reimbursement 
- Since 2011-Established ISPOR (International Society For 
Pharmacoeconomics and Outcomes Research) Macedonia Chapter
HTA in Macedonia
• Ministry of Health with Agency for Medicines and 
Medical Devices have developed TOR,s for DTC (according 
to WHO recommendations)
• DTC is a multi-disciplinary team of doctors, pharmacists, 
hospital managers and other professionals , it is expected 
to improve rational use of drugs and reduce hospital 
costs by: 
-giving advice in all aspects of drug management
-developing drug policies
-evaluation and selection of drugs for Positive list
HTA IN MACEDONIA
- developing and implementing standard treatment 
guidelines
- assessing drug use to identify problems
- Conducting interventions to improve drug use
- managing adverse drug reactions and medication errors
- informing all staff members about drug use issues, 
policies and decisions.
At the moment there is no evaluation of the work of DTC
ISPOR Macedonia Chapter
• Provides an environment where researchers, health care 
practitioners, and decision-makers interested in 
pharmacoeconomics and outcomes research can share knowledge 
at a country level.
• 1st Macedonian and 4th Adriatic Congress on Pharmacoeconomics 
and Outcomes Research, April 2014
“Impact of Health Economic Assessments on Health Policy 
Decisions"
• Publication: Health Care Cost, Quality, and Outcomes: ISPOR Book of 
Terms – translated into Macedonian
• This book provides a great contribution to the mission of the ISPOR 
Macedonia chapter and presents a great value to solving problems 
related to Pharmacoeconomics
• Over the last decade, Clinical guidelines are recognized as particularly 
important in the context of the current challenges facing the overall 
health care systems, such as the rising costs of health care, 
introduction of expensive new technologies, increased demand for 
care combined with an ageing population, the variations in clinical 
practice and service delivery patterns among health care 
professionals, institutions and geographical regions. 
• Although target users of the clinical guidelines are usually considered 
the physicians, other groups may benefit too, including nurses and 
midwives, paramedical professions, health managers, policymakers 
and patients.  All of them perceive increasingly clinical guidelines as 
relevant tools for making health care more efficient, consistent, safer 
and for eliminating the differences between what clinicians do and 
what scientific evidence has demonstrated. 
Evidence-based practice in the country
Evidence-based practice in the country
Clinical guidelines are used for the following purposes:
• To inform health care policy for prioritization of needs and 
support rational and evidence-based health care decisions; 
• To help develop standards for improving quality of care, change 
the provision of health care, help assess the clinical practice 
and improve outcomes for patients; 
• To provide information on cost effectiveness and ensure 
efficient use of resources which is pertinent to modelling 
health economics;
• To educate and train health care professionals to deliver high-
quality care;
• To strengthen the position of the patient and enhance patient-
provider partnership;
• To reduce litigation costs by reducing poor clinical practice. 
Major actions taken
• The concept was introduced almost ten years ago
• Highly professional working groups established for each 
clinical field
• Adopted and adapted the most relevant Clinical Guidelines in 
all disciplines, period for update predefined 
• Legal obligation for health care practitioners stated and 
published in “Official Gazette of the Republic of Macedonia” 
• Clinical pathways created in accordance with the Clinical 
Guidelines
• Monitoring and evaluation of the implementation through the 
Health Insurance Fund and Agency for Quality and 
Accreditation of Healthcare Institutions
Additional important steps completed
• Established School for practicing Evidence Based Medicine under the 
auspices of the Faculty for medical sciences, University in Stip 
• UNFPA supported activities: 
• Regional workshop on Guidelines development/adoption/adaptation and 
roll out national trainings were continued
• Skills for proper management of the process of adaptation were acquired 
(currently: ongoing process for adaptation of the CG for PPH)
• Introduction of the BTN methodology for maternal deaths review
• The overall goal of this initiative was to contribute towards improving 
quality of care in the country, starting with maternal and neonatal health. 
This would be achieved through harmonization and institutionalization of 
the process of adaptation of existing international guidelines.  
Furthermore, practical issues around implementation of new national 
guidelines into clinical practice would be identified and solutions would be 
proposed. 
Clinical guidelines
• In the country, the international definitions for Guidelines, 
protocols, pathways and algorithms are completely accepted
• For the term “Clinical guidelines” the updated  definition is used to 
reflect the essential defining characteristics: “clinical practice 
guidelines are statements that include recommendations intended 
to optimize patient care that are informed by a systematic review of 
evidence and an assessment of the benefits and harms of 
alternative care options”.
• Broadly defined, clinical guidelines make recommendations for the 
health care professionals based on the best available evidence, for 
the care of patients.  
• Evidence-based clinical guidelines have become an integral 
part of health care systems and are considered to be essential 
tools for improving the quality of primary, secondary and 
tertiary health care.  They have been developed to achieve 
value for money.  
• The principal aim of evidence-based clinical guidelines is to 
improve the effectiveness and efficiency of clinical care, as 
well as patient safety by supporting and promoting good 
clinical practice in the best interest of patients. 
• Although guidelines provide mainly evidence-based advice for 
clinical care, they can also be used to set standards of care, 
improve training and influence the research portfolio.
• Policy makers can also use the recommendations made in the 
guidelines  for commissioning services.
• Implementation  of guidelines also helps to improve 
communication and shared decision-making between patients  
and health care professionals.
•
Clinical protocols
• Clinical protocols are documents at local (institution, department or 
clinic) health care level, which are used to implement the national 
clinical guidelines, in order to improve quality of care and reduce 
inequalities in provision of care and should also be updated 
regularly.  They are derived from the national clinical guidelines and 
reflect the local circumstances and variations due to different types 
of clinical care at different levels.   
• Clinical protocols set out precise rules and sequences of activities to 
be adhered to in the management of specific clinical conditions.  
They set out specifically what should happen, when and by whom in 
the care process.  They are intended to be applied rigidly and must 
be followed virtually in all cases in a defined medical situation, 
allowing little or no flexibility or variation.  
Clinical/care pathways
• Clinical pathways are tools used to guide health professionals 
at local (institution, department or clinic) health care level, 
with the aim to improve the quality of care throughout the 
patient journey.  There is still no standardized definition of 
what a “clinical pathway” actually constitutes. 
• Integrated care pathway is usually used if care pathways are 
multi-disciplinary and/or across sectors of health care 
provision.  
Algorithms
• An algorithm is a flow chart of the clinical decision pathway 
described in the guideline. 
• The algorithm forms the basis of a shorter form of the 
guideline, intended for quick reference.  It is only a 
summarization of the recommendations and should not 
include any further detailed information or advice.  
• It may be necessary to produce more than one algorithm for 
one clinical guideline, if the recommendations cannot be 
summarized into one flow chart. 
Standards
• The term standard may be used to define the exact quantity or 
the degree of fulfilment of a criterion for an adequate, 
acceptable or optimal level of quality.  Used in this sense, it 
indicates an objective set to be achieved or considered as being 
achievable.  
• A standard of care is a statement which provides an overview 
of relevant evidence in areas that have some influence or effect 
on day-to-day clinical practice, but does not provide specific 
recommendations.  It expresses the quality of care provided 
and focuses on care that is effective, safe and provides a good 
patient experience.  
Agency for Quality and Accreditation of 
HC Institutions in Republic of Macedonia
• Standards for Quality of care developed and  accepted by the 
Government of Macedonia
• The standards are based on high level of evidence 
• Process of hospital preparation in place
• Procedures, process of implementation…
• Membership in International Society for Quality of Care 
(ISQua)
• Close collaboration with hospital management
• Interinstitutional collaboration  (MoH, HIF, State Sanitary 
Health Inspectorate)
Joining EVIPnet
• EVIPNet promotes partnerships at the country level 
between health system policy-makers and other 
stakeholders including researchers, civil society, funders, 
and health professionals to enhance the profile of research 
evidence as a central input to policy-making. 
• Purpose: To provide background on knowledge translation: 
the synthesis, exchange and application of knowledge by 
relevant stakeholders to accelerate the benefits of 
innovation in strengthening health systems and improving 
people’s health
What is EVIPnet?
• Evidence briefs for policy, formerly known as policy briefs, 
are one in a core set of tools used to support evidence-
informed policy-making. 
• Existing evidence syntheses, such as the gold standard 
systematic review, are of limited use for policy-makers since 
they require evidence to be adapted to a local context. 
• Evidence briefs go beyond the systematic review by not only 
addressing the question, but also framing the research 
evidence in conjunction with information that is specifically 
relevant for health system policy-makers and stakeholders. 
Objectives
• improve the culture for and practice of research evidence 
creation, adaptation and use;
• influence processes and mechanisms supporting  the 
prioritization of timely and relevant research  evidence;
• package and disseminate research evidence;
• support the development of evidence brief for policy in 
public health
• convene national dialogues about priority public health  
challenges;
• enhance capacity to find and use research evidence and to 
develop evidence brief for policy
• catalyze KT at the global level. 
Priority topics
- Human resources for Health 
- Vaccine and Immunization
- Health Insurance coverage
- Access to health services
- Quality of primary health care services- Nutrition
- Patient safety
- Mental health
- Tobacco
- Rare diseases
- Maternal and neonatal mortality
- Gender and health systems 
National workshop in Skopje
• Under the guidance of the WHO Country Office and the 
relevant WHO/EURO technical unit and in close cooperation 
with all relevant national stakeholders, the initiative was 
taken on the topic, taking into consideration the WHO 
documents/guidelines, followed by discussions of the invited 
stakeholders on the needs and possibilities for strengthening 
the EVIPNet process on national level, reaching conclusions 
and providing recommendations for the process 
advancement. 

